semaglutide ohio weighless wellness clinic for Weight Loss in Cleveland: GLP-1 Injections at NuIQ Lounge & Med Spa Semaglutide Ozempic & Wegovy Programs

Results from Eli Lilly's Phase 2 trial (Jastreboff et al., New England Journal of Medicine, 2023) reported mean body weight reductions of approximately 1724% over 48 weeks depending on dose, which has generated considerable scientific interest

Many individuals on GLP-1 therapy who incorporate weight training and sufficient protein intake find that they not only lose substantial fat but also maintain or even increase their lean mass

Are there alternatives for weight loss

and Lee, D.G., Res

New England Journal of Medicine, 385(6), 503515

GLP-1 medications slow gastric emptying and affect appetite-regulating hormones, which can trigger nausea as a side effect